https://www.neurologylive.com/view/published-space-study-reinforces-efficacy-fremanezumab-pediatric-episodic-migraine
Published SPACE Study Reinforces Efficacy of Fremanezumab for Pediatric Episodic Migraine |...
Oct 16, 2026 - Fremanezumab, a humanized monoclonal antibody that selectively targets calcitonin gene–related peptide, demonstrated efficacy in children and adolescents with...
episodic migrainepublishedspacestudyreinforces
https://practicalneurology.com/news/galcanezumab-reduces-episodic-and-chronic-migraine-pain-burden/2469299/
Galcanezumab Reduces Episodic and Chronic Migraine Pain Burden - Practical Neurology
Galcanezumab (Emgality; Eli Lilly, Indianapolis, IN) reduced total pain burden in a recent analysis of individuals with episodic and chronic migraine. Tot…
chronic migrainepractical neurologygalcanezumabreducesepisodic
https://researchascare.com/study/episodic-migraine/
Episodic Migraine | Find a Trial
find a trialepisodic migraine
https://centaur.reading.ac.uk/39622/
Cortical hot spots and labyrinths: why cortical neuromodulation for episodic migraine with aura...
migraine with aurahot spotscorticallabyrinthsneuromodulation
https://practicalneurology.com/news/update-on-migraine-incidence-of-migraine-and-risk-for-progression-from-episodic-to-chronic-migraine/2469439/
Update on Migraine Incidence and Risk for Progression from Episodic to Chronic Migraine - Practical...
At the Virtual Scottsdale Headache Symposium 2020, Richard Lipton, MD presented the latest data from epidemiology studies of migraine. Dr. Lipton noted th…
updatemigraineincidenceriskprogression